Groupe Hospitalier du Havre Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2018
NCT03626519
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Groupe Hospitalier du Havre